June 20, 2020
Alliance for Human Research Protection (AHRP)
“On June 14th, Dr. Nass first identified two Covid-19 experiments in which massive, high toxic doses – four times higher than usual of hydroxychloroquine – were being given to severely ill hospitalized patients in intensive care units.
- Solidarity was being conducted by the World Health Organization, on 3500 Covid-19 patients at 400 hospitals, across 35 countries. The hydroxychloroquine arm of the trial was suspended May 25th following the fraudulent Surgisphere report in The Lancet that claimed 35% higher death rates in patients receiving Hydroxychloroquine. But when The Lancet retracted the report, the WHO resumed the Solidarity trial’s hydroxychloroquine arm, on June 3rd. More than 100 countries expressed interest in participating in the trial.
- Recovery is a similar experimental trial conducted in the UK, using very similar doses. It was sponsored by the Wellcome Trust (GlaxoSmithKline) and the Bill and Melinda Gates Foundation and the UK government. The experiment was conducted at Oxford University, on 1,542 patients of these 396 patients (25.7%) died.
Update: After Dr. Nass’ discovery was publicly disseminated, the WHO suspended the hydroxychloroquine arm of the trial [Solidarity] on Wednesday June 17th.”
Copyright 2023 Alliance for Human Research Protection
document
COVID-19,hydroxychloroquine,medical treatments,pharmaceuticals